These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1223998)

  • 1. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.
    Bunney BS; Walters JR; Kuhar MJ; Roth RH; Aghajanian GK
    Psychopharmacol Commun; 1975; 1(2):177-90. PubMed ID: 1223998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of crus cerebri lesions and repeated amphetamine treatment on the activity of nigral dopaminergic neurons.
    Heidenreich BA; Rebec GV
    Synapse; 2000 Oct; 38(1):80-6. PubMed ID: 10941143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of tetrahydropalmatine enantiomers on firing activity of dopamine neurons in substantia nigra pars compacta.
    Sun BC; Huang KX; Jin GZ
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):292-7. PubMed ID: 1360741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Amphetamine-induced inhibition of central dopaminergic neurons: direct effect or mediated by a striatonigral feedback pathway?
    Bunney BS; Aghajanian GK
    Adv Biochem Psychopharmacol; 1977; 16():577-82. PubMed ID: 883560
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons.
    Souto M; Monti JM; Altier H
    Pharmacol Biochem Behav; 1979 Jan; 10(1):5-9. PubMed ID: 441095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
    Piercey MF; Smith MW; Lum-Ragan JT
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1297-303. PubMed ID: 8138943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors.
    Shi WX; Pun CL; Smith PL; Bunney BS
    Synapse; 2000 Feb; 35(2):111-9. PubMed ID: 10611636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
    Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
    Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the serotonin 5-HT(7) receptor antagonist SB-269970 on the inhibition of dopamine neuronal firing induced by amphetamine.
    Mnie-Filali O; Dahan L; Zimmer L; Haddjeri N
    Eur J Pharmacol; 2007 Sep; 570(1-3):72-6. PubMed ID: 17586491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pallidal control of substantia nigra dopaminergic neuron firing pattern and its relation to extracellular neostriatal dopamine levels.
    Lee CR; Abercrombie ED; Tepper JM
    Neuroscience; 2004; 129(2):481-9. PubMed ID: 15501605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine elicited potential changes in vertebrate and invertebrate central neurons.
    Tsai MC; Chen YH; Huang SS
    Acta Biol Hung; 2000; 51(2-4):275-86. PubMed ID: 11034152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine normalizes the electrical activity of dopamine neurons in the ventral tegmental area following prenatal ethanol exposure.
    Xu C; Shen RY
    J Pharmacol Exp Ther; 2001 May; 297(2):746-52. PubMed ID: 11303066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.
    Sotty F; Montezinho LP; Steiniger-Brach B; Nielsen J
    J Neurochem; 2009 May; 109(3):766-75. PubMed ID: 19236563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midbrain dopamine neurons: differential responses to amphetamine isomers.
    Browder S; German DC; Shore PA
    Brain Res; 1981 Mar; 207(2):333-42. PubMed ID: 7470912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity.
    Akaoka H; Roussel B; Lin JS; Chouvet G; Jouvet M
    Neurosci Lett; 1991 Feb; 123(1):20-2. PubMed ID: 1676498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.